Top-News

Sehen Sie sich dieses Unternehmen an: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $(Anzeige)

Handeln

GlycoMimetics News


1,64 $		-4,09%	-0,07 $

In : 1,5337 € | 26.04.24 22:00:00 Nasdaq

aktualisieren | Orderbuch | Mehr Kurse »

WKN: A1W8HZ

ISIN: US38000Q1022

US-Symbol: GLYC

Typ: Aktie

GlycoMimetics News

23.10.23 - PR Newswire

Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board

Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board PR Newswire

29.12.22 - PR Newswire

Thinking about buying stock in Baudax Bio, Kala Pharmaceuticals, GlycoMimetics, Pagaya Technologies, or Transcode Therapeutics?

Thinking about buying stock in Baudax Bio, Kala Pharmaceuticals, GlycoMimetics, Pagaya Technologies, or Transcode Therapeutics? PR Newswire

07.09.21 - PR Newswire

Thinking about buying stock in Adaptimmune Therapeutics, Ziopharm Oncology, Uniqure NV, GlycoMimetics, or AbCellera Biologics?

Thinking about buying stock in Adaptimmune Therapeutics, Ziopharm Oncology, Uniqure NV, GlycoMimetics, or AbCellera Biologics? PR Newswire

26.08.14 - PR Newswire

BioMed Realty Signs New Lease With GlycoMimetics At Its Newly Redeveloped Center For Life Science | Shady Grove Campus In Rockville, Maryland

BioMed Realty Signs New Lease With GlycoMimetics At Its Newly Redeveloped Center For Life Science | Shady Grove Campus In Rockville, Maryland Biotechnology Company ...

Newssuche

Videos

26.04.24 +6,31%

Technical Trading: Gold Long freitags

Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »

Sehen Sie sich dieses Unternehmen an:

Foto: andreas160578 - Pixabay

Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
weiterlesen»

Anzeige